Research Participant Interest in Alzheimer’s Disease Biomarker Disclosure

por Erickson, Claire, Chin, Nathaniel, Gleason, Carey, Johnson, Sterling, Clark, Lindsay
Publicado 2020

Predictors of positive or negative reactions to learning Alzheimer’s biomarker results

por Erickson, Claire, Chin, Nate, Jonaitis, Erin, Ketchum, Fred, Gleason, Carey, Clark, Lindsay
Publicado 2021

Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know

por Erickson, Claire M., Chin, Nathaniel A., Johnson, Sterling C., Gleason, Carey E., Clark, Lindsay R.
Publicado 2021

Feasibility of virtual Alzheimer's biomarker disclosure: Findings from an observational cohort

por Erickson, Claire M., Chin, Nathaniel A., Rosario, Hannah L., Peterson, Amanda, Johnson, Sterling C., Clark, Lindsay R.
Publicado 2023

Occupational-like organophosphate exposure disrupts microglia and accelerates deficits in a rat model of Alzheimer’s disease

por Voorhees, Jaymie R., Remy, Matthew T., Erickson, Claire M., Dutca, Laura M., Brat, Daniel J., Pieper, Andrew A.
Publicado 2019

The importance of the dyad: Participant perspectives on sharing biomarker results in Alzheimer's disease research

por Ketchum, Fred B., Chin, Nathaniel A., Erickson, Claire, Lambrou, Nickolas H., Basche, Kristin, Gleason, Carey E., Clark, Lindsay
Publicado 2023

Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society

por Erickson, Claire M., Clark, Lindsay R., Ketchum, Fred B., Chin, Nathaniel A., Gleason, Carey E., Largent, Emily A.
Publicado 2022

Predictors of Willingness to Enroll in Hypothetical Alzheimer Disease Biomarker Studies that Disclose Personal Results

por Erickson, Claire M., Chin, Nathaniel A., Ketchum, Frederick B., Jonaitis, Erin M., Zuelsdorff, Megan L., Gleason, Carey E., Clark, Lindsay R.
Publicado 2022

What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer’s Disease Biomarker Research? A Qualitative Vignette Analysis

por Ketchum, Fred B., Erickson, Claire M., Chin, Nathaniel A., Gleason, Carey E., Lambrou, Nickolas H., Benton, Susan Flowers, Clark, Lindsay R.
Publicado 2022

Virtual disclosure of preclinical Alzheimer's biomarkers: Preliminary experiences

por Erickson, Claire M., Chin, Nathaniel A., Coughlin, DaRae M., Conway, Camille E., Rosario, Hannah L., Johnson, Sterling C., Clark, Lindsay R.
Publicado 2021

Anticipated reactions to learning Alzheimer’s disease biomarker results

por Clark, Lindsay R., Erickson, Claire M., Jonaitis, Erin M., Ma, Yue, Chin, Nathaniel A., Basche, Kristin, Ketchum, Frederick B., Gleason, Carey E.
Publicado 2022

Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing

por Ketchum, Fred B., Chin, Nathaniel A., Grill, Joshua, Gleason, Carey E., Erickson, Claire, Clark, Lindsay R., Paulsen, Jane S., Kind, Amy J.H.
Publicado 2022

Prescription Medications and Co-Morbidities in Late Middle-Age are Associated with Greater Cognitive Declines: Results from WRAP

por Du, Lianlian, Koscik, Rebecca Langhough, Chin, Nathaniel A., Bratzke, Lisa C., Cody, Karly, Erickson, Claire M., Jonaitis, Erin, Mueller, Kimberly D., Hermann, Bruce P., Johnson, Sterling C.
Publicado 2022

Cardiology clinic patient attitudes toward and potential personal utility of genetic testing: Findings from a unique multiracial clinical sample

por Erickson, Claire M., Clark, Lindsay R., Umucu, Emre, Vo, Nhi H., Volgman, Annabelle Santos, Chin, Nathaniel A., Ketchum, Fred B., Jones, Carolyn H., Gleason, Carey E., Aggarwal, Neelum T.
Publicado 2022

Associations of the Lifestyle for Brain Health index with longitudinal cognition and brain amyloid beta in clinically unimpaired older adults: Findings from the Wisconsin Registry...

por Cody, Karly A., Koscik, Rebecca L., Erickson, Claire M., Berman, Sara E., Jonaitis, Erin M., Williams, Victoria J., Mueller, Kimberly D., Christian, Bradley T., Chin, Nathanial A., Clark, Lindsay R., Betthauser, Tobey J., Johnson, Sterling C.
Publicado 2022

Trajectory of clinical symptoms in relation to amyloid chronicity

por Birdsill, Alex C., Koscik, Rebecca L., Cody, Karly A., Jonaitis, Erin M., Cadman, Robert V., Erickson, Claire M., Chin, Nathaniel A., Przybelski, Robert J., Carlsson, Cynthia M., Asthana, Sanjay, Christian, Bradley T., Eisenmenger, Laura B., Betthauser, Tobey J., Johnson, Sterling C.
Publicado 2022

Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age

por Betthauser, Tobey J, Koscik, Rebecca L, Jonaitis, Erin M, Allison, Samantha L, Cody, Karly A, Erickson, Claire M, Rowley, Howard A, Stone, Charles K, Mueller, Kimberly D, Clark, Lindsay R, Carlsson, Cynthia M, Chin, Nathaniel A, Asthana, Sanjay, Christian, Bradley T, Johnson, Sterling C
Publicado 2020